Back to funds
View filing
Verdad Advisers, LP
hedge fundUpdated 27 days agoManaged by Verdad Advisers, Lp • Latest filing Q2 2026
Portfolio value
$104.4M
Q2 2026
Filings
10
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
38.1%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 10 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $49.7M |
| Q2 2023 | $63.8M |
| Q3 2023 | $65.4M |
| Q4 2023 | $49.3M |
| Q1 2024 | $91.9M |
| Q2 2024 | $86.6M |
| Q3 2024 | $74.9M |
| Q4 2025 | $87.4M |
| Q1 2026 | $88.8M |
| Q2 2026 | $104.4M |
Top holdings
210 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | A AAPL APPLE INC | $2.2M | 7.4K | 2.06% | — |
| 2 | B BLTE BELITE BIO INC | $2.1M | 13.8K | 2.03% | — |
| 3 | A ACAD ACADIA PHARMACEUTICALS INC | $2.1M | 82.6K | 2.00% | — |
| 4 | C CCZ COMCAST CORP NEW | $2.1M | 84.6K | 1.99% | — |
| 5 | C CLDT-PA CHATHAM LODGING TR | $1.9M | 140.0K | 1.77% | — |
| 6 | ? N/A TENAX THERAPEUTICS INC | $1.8M | 123.2K | 1.72% | — |
| 7 | S SLDE SLIDE INS HLDGS INC | $1.8M | 91.1K | 1.69% | — |
| 8 | Z ZYME ZYMEWORKS INC | $1.7M | 66.7K | 1.67% | — |
| 9 | A AMN AMN HEALTHCARE SVCS INC | $1.7M | 51.9K | 1.61% | — |
| 10 | ? N/A X4 PHARMACEUTICALS INC | $1.6M | 352.1K | 1.57% | — |
| 11 | V VSNT VERSANT MEDIA GROUP INC | $1.6M | 43.5K | 1.50% | — |
| 12 | N NTCT NETSCOUT SYS INC | $1.4M | 33.1K | 1.38% | — |
| 13 | ? N/A WHITEHAWK THERAPEUTICS INC | $1.4M | 301.5K | 1.32% | — |
| 14 | J JNJ JOHNSON & JOHNSON | $1.4M | 5.4K | 1.31% | — |
| 15 | C CTNM CONTINEUM THERAPEUTICS INC | $1.3M | 81.0K | 1.27% | — |
| 16 | J JBIO JADE BIOSCIENCES INC | $1.3M | 56.4K | 1.20% | — |
| 17 | C CSCO CISCO SYS INC | $1.2M | 10.3K | 1.16% | — |
| 18 | N NRIX NURIX THERAPEUTICS INC | $1.2M | 49.5K | 1.15% | — |
| 19 | T TARA PROTARA THERAPEUTICS INC | $1.2M | 312.2K | 1.14% | — |
| 20 | B BLMN BLOOMIN BRANDS INC | $1.2M | 130.0K | 1.14% | — |